The 2026 Clinical Obesity review found GLP-1 users running 2630% lower ferritin than comparison groups, and a separate analysis of 18,746 adults with type 2 diabetes found GLP-1 users had a 54% higher likelihood of lower ferritin than users of a different diabetes drug class
None of the other GLP-1RAs are recommended for use in the pediatric population
More recent DSIP research has been largely preclinical, mechanistic (focused on how DSIP may work biologically rather than whether it produces proven benefits in humans), or exploratory rather than large-scale human outcome research [16][17]
After blood flow recovery, mitochondrial permeability increases because of the high-level calcium, and moreover, succinate, mtDNA, and other substances are released
Symptoms such as burning while urinating, fever, pelvic pain, or blood in the urine should always be medically assessed promptly